Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Rad

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Nature|January 25, 2018
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Thomas Engleitner, Roman Maresch, et al.
Cancer Research|May 11, 2026
ATM Deficiency Induces TGF-β-Mediated Stromal Programming in Pancreatic CancerElodie Roger, Hannah M Mummey, Eleni Zimmer, et al.
Blood|September 27, 2023
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyDaria Frank, Pradeep Kumar Patnana, Jan Vorwerk, et al.
Nature|July 10, 2024
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infectionMiriam Bosch, Nina Kallin, Sainitin Donakonda, et al.
Nature|February 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolutionSebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler, et al.
Nature Medicine|April 3, 2019
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancerMohsen Malehmir, Dominik Pfister, Suchira Gallage, et al.
Nature|June 23, 2012
The landscape of cancer genes and mutational processes in breast cancerPhilip J Stephens, Patrick S Tarpey, Helen Davies, et al.
Journal of Hepatology|May 24, 2023
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signallingElena Kotsiliti, Valentina Leone, Svenja Schuehle, et al.
Nature|September 10, 2025
Functional synapses between neurons and small cell lung cancerVignesh Sakthivelu, Anna Schmitt, Franka Odenthal, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Nature|January 25, 2018
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Thomas Engleitner, Roman Maresch, et al.
Cancer Research|May 11, 2026
ATM Deficiency Induces TGF-β-Mediated Stromal Programming in Pancreatic CancerElodie Roger, Hannah M Mummey, Eleni Zimmer, et al.
Blood|September 27, 2023
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyDaria Frank, Pradeep Kumar Patnana, Jan Vorwerk, et al.
Nature|July 10, 2024
A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infectionMiriam Bosch, Nina Kallin, Sainitin Donakonda, et al.
Nature|February 25, 2026
A disease model resource reveals core principles of tissue-specific cancer evolutionSebastian Mueller, Niklas de Andrade Krätzig, Markus Tschurtschenthaler, et al.
Nature Medicine|April 3, 2019
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancerMohsen Malehmir, Dominik Pfister, Suchira Gallage, et al.
Nature|June 23, 2012
The landscape of cancer genes and mutational processes in breast cancerPhilip J Stephens, Patrick S Tarpey, Helen Davies, et al.
Journal of Hepatology|May 24, 2023
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signallingElena Kotsiliti, Valentina Leone, Svenja Schuehle, et al.
Nature|September 10, 2025
Functional synapses between neurons and small cell lung cancerVignesh Sakthivelu, Anna Schmitt, Franka Odenthal, et al.
Nature|March 25, 2021
NASH limits anti-tumour surveillance in immunotherapy-treated HCCDominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, et al.
Pageof 21